XNAS · Technology · Scientific & Technical Instruments
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
CEO Gary Owens' departure amid transition creates leadership uncertainty. Massive **$1.83 EPS beat** offset by revenue miss and declining margins signal operational challenges.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | Q4 2026 | 1.47 | 3.30 | +124.49% | $63.7M | ✅ Beat | -2.04% | +14.96% | — |
| 2026-02-03 | Q3 2026 | 1.60 | 3.07 | +91.87% | $65.1M | ✅ Beat | +5.59% | +5.05% | +0.07% |
| 2025-11-06 |
| Q2 2026 |
| 1.72 |
| 2.75 |
| +59.88% |
| $60.7M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-05 | Q1 2026 | 2.03 | 2.32 | +14.29% | $59.5M | ✅ Beat | -2.09% | +10.15% | +12.00% |
| 2025-02-04 | Q3 2025 | 1.51 | 2.72 | +80.13% | $62.8M | ✅ Beat | +1.19% | +9.64% | +0.68% |
| 2024-11-07 | Q2 2025 | 1.38 | 2.62 | +89.86% | $57.8M | ✅ Beat | +0.81% | -11.27% | +11.17% |
| 2024-06-05 | Q4 2024 | 2.33 | 2.77 | +18.88% | $58.9M | ✅ Beat | +0.14% | -10.99% | -14.66% |
| 2024-02-05 | Q3 2024 | 0.19 | 2.02 | +963.16% | $53.5M | ✅ Beat | — | — | — |
Showing last 8 quarters.